The 7th Annual Pharma Manufacturing & Automation Convention (PM&AC) 2025, co-located with the Pharma Manufacturing & ...

Cambridge, Massachusetts Friday, October 24, 2025, 18:00 Hrs [IST] ...

NU Hospitals with Medlern and Laerdal Medical to enhance clinical training through advanced modular skills training: Our Bureau, Bengaluru Friday, October 24, 2025, 17:45 Hrs [IST ...

Vaayu Chest and Sleep Specialty Center’s REVIVE 2025 underscores need for multidisciplinary collaboration: Our Bureau, Bengaluru Friday, October 24, 2025, 17:30 Hrs [IST] Vaayu ...

Horus Pharma inks agreement to commercialize Formycon’s aflibercept biosimilar FYB203 under the brand name Baiama across Key European Markets including its home market France ...

SecondWave Systems to expanded Series A syndicate to speed up development of ultrasound-based anti-inflammatory treatment: St. Paul, Minnesota Friday, October 24, 2025, 15:00 Hrs ...

Emeryville, California Friday, October 24, 2025, 14:00 Hrs [IST] ...

US FDA grants fast track designation to AnnJi Pharma’s AJ201, a first-in-class therapy for Kenndy’s disease: Taipei City, Taiwan Friday, October 24, 2025, 13:00 Hrs [IST] AnnJ ...

Non-profit patient advocacy groups, patient groups and others in various parts of the world have come together to launch a community-run buyers' club to access a new generic version of a lifesaving ...

Biodesix announces expanded Bio-Rad Laboratories partnership agreement to develop Droplet Digital PCR high complexity assays: Louisville, Colorado Friday, October 24, 2025, 12:00 ...

Forlong Biotechology inks agreement with Shanghai Henlius Biotech to develop cancer immunotherapy: Shanghai Friday, October 24, 2025, 17:00 Hrs [IST] Forlong Biotechnology, a clin ...

Global pharma major Lupin Limited (Lupin) announced the launch of an authorized generic version of Ravicti (glycerol phenylbutyrate) oral liquid, 1.1g/mL, in the United States. Glycerol phenylbutyrate ...